ABSTRACT
Objective To ascertain the accuracy of 2 upper-arm blood pressure monitors, GE Carescape V100 Vital Signs and Omron HEM-9210T, used in a large, South-East Asian epidemiological cohort by the AAMI/ESH/ISO 81060-2:2018.
Methods 149 participants were recruited from the ongoing Health for Life in Singapore (HELIOS) Study in multi-ethnic Singapore.
Results 110 datasets were analysed. For criterion 1, the mean ± SD of differences for GE Carescape V100 was -3.5 ± 7.4/ -3.5 ± 7.4 mmHg (systolic/diastolic), and -4.2 ± 6.9/ -4.2 ± 6.9 mmHg (systolic/diastolic) for Omron HEM-9210T. For criterion 2, GE Carescape V100was -3.5 ± 5.6 / -3.5 ± 5.6 mmHg (systolic/diastolic), and -4.2 ± 4.5 / - 4.2 ± 4.6 mmHg (systolic/diastolic) for Omron HEM-9210T.
Conclusion Both GE Carescape V100 Vital Signs and Omron HEM-9210T monitor passed the AAMI/ESH/ISO 81060-2:2018 validation standard.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The is part of the Health for Life in Singapore (HELIOS) Study. HELIOS is supported by the Lee Kong Chian School of Medicine, Nanyang Technological University and National Healthcare Group, Singapore. J.C. is supported by the Singapore Ministry of Health National Medical Research Council under its STaR funding scheme [NMRC/STaR/0028/2017]. T.M. received postdoctoral fellowship from the Singapore Ministry of Education Research Scholarship Block and Lee Kong Chian School of Medicine.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Nanyang Technological University Institutional Review Board of Nanyang Technological University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
CONFLICTS OF INTEREST None declared.
SOURCE OF FUNDING JCC, MLCS and THM are supported by the intramural funding from NTU LKCMedicine, and the National Healthcare Group. JCC is supported by the Singapore Ministry of Health’s National Medical Research Council under its’ STaR funding scheme [NMRC/STaR/0028/2017]. THM received postdoctoral fellowship from the Singapore Ministry of Education – Research Scholarship Block and NTU LKCMedicine.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
